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Alteration in cholesterol metabolism has been implicated in the pathogenesis of several
neurodegenerative disorders. Apolipoprotein E (ApoE) is the major component of brain
lipoproteins supporting cholesterol transport. We previously reported that the acute-phase
protein Haptoglobin (Hpt) binds ApoE, and influences its function in blood cholesterol
homeostasis. Major aim of this study was to investigate whether Hpt influences the
mechanisms by which cholesterol is shuttled from astrocytes to neurons. In detail
it was studied Hpt effect on ApoE-dependent cholesterol efflux from astrocytes and
ApoE-mediated cholesterol incorporation in neurons. We report here that Hpt impairs
ApoE-mediated cholesterol uptake in human neuroblastoma cell line SH-SY5Y, and limits
the toxicity of a massive concentration of cholesterol for these cells, while it does not
affect cholesterol efflux from the human glioblastoma-astrocytoma cell line U-87 MG.
As aging is the most important non-genetic risk factor for various neurodegenerative
disorders, and our results suggest that Hpt modulates ApoE functions, we evaluated
the Hpt and ApoE expression profiles in cerebral cortex and hippocampus of adolescent
(2 months), adult (5 and 8 months), and middle-aged (16 months) rats. Hpt mRNA
level was higher in hippocampus of 8 and 16 month-old than in 2-month old rats
(p < 0.05), and Hpt concentration increased with the age from adolescence to middle-age
(p < 0.001). ApoE concentration, in hippocampus, was higher (p < 0.001) in 5 month-old
rats compared to 2 month but did not further change with aging. No age-related changes
of Hpt (protein and mRNA) were found in the cortex. Our results suggest that aging
is associated with changes, particularly in the hippocampus, in the Hpt/ApoE ratio.
Age-related changes in the concentration of Hpt were also found in human cerebrospinal
fluids. The age-related changes might affect neuronal function and survival in brain, and
have important implications in brain pathophysiology.
Keywords: haptoglobin, apolipoprotein E, cholesterol, aging, human neuroblastoma cell line SH-SY5Y, human
astrocytoma cell line U-87 MG, hippocampus, cerebrospinal fluid
INTRODUCTION
Cholesterol is a key component of biological membranes, par-
ticipates in the modulation of their fluidity, and is the precur-
sor of several signaling molecules, including steroid hormones
(Tabas, 1997; Simons and Ikonen, 2000). Approximately 25%
of the total body cholesterol resides in the brain (Dietschy and
Turley, 2001), mostly in the myelin sheath that surrounds the
axons, where facilitates the transmission of electrical signals and
plays a crucial role in the development and maintenance of neu-
ronal plasticity and function (Pfrieger, 2003). The blood-brain
barrier prevents the uptake of this lipid from the circulation
(Dietschy and Turley, 2004), hence the majority of cholesterol
present in this organ is synthesized in situ (Dietschy and Turley,
2001; Pfrieger and Ungerer, 2011). In particular, as intracellular
synthesis is down regulated in the mature brain, neurons meet
their cholesterol requirements essentially via uptake of choles-
terol carried in Apolipoprotein E (ApoE)-containing lipoproteins
secreted by glial cells (Pfrieger, 2003). This specific brain lipopro-
tein transport system very efficiently recycles cholesterol, and
mainly depends on the presence of ApoE (Verghese et al., 2011).
Astrocytes release cholesterol and ApoE that are assembled with
phospholipids into lipoprotein particles, which are similar in size
to plasma HDL (Boyles et al., 1985; DeMattos et al., 2001; Pfrieger
and Ungerer, 2011). These lipoproteins interact, via ApoE, with
the low-density lipoprotein receptor (LDLR) and with the low-
density lipoprotein receptor-related protein 1 (LRP1), expressed
in neurons (Boyles et al., 1989; Posse de Chaves et al., 2000;
Herz, 2009), thus delivering cholesterol for growth, repair, and
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synaptogenesis (Posse de Chaves et al., 1997; Mauch et al., 2001;
Hayashi et al., 2004). In this way, cholesterol is shuttled from
astrocytes to neurons (Mauch et al., 2001; Vance and Hayashi,
2010). The maintenance of the correct balance of cholesterol
is critical for neuronal function, and any alteration in choles-
terol levels may severely affect brain performance. The decay
on such performance is one of the hallmarks of aging. In addi-
tion, impaired brain cholesterol distribution and metabolism
has been pointed to as likely involved in the pathogenesis of
Alzheimer’s disease (AD), and other neurodegenerative diseases
(Solomon et al., 2007; Foley, 2010; Vance, 2012). The precise
mechanisms underlying the association between altered choles-
terol metabolism and neurodegenerative diseases have not been
clarified yet. Since ApoE plays a key role in regulating choles-
terol homeostasis in the brain (Vance and Hayashi, 2010), it
is conceivable that ligands modulating its functions might have
critical effect on brain physiology. In this frame, our group previ-
ously reported that Haptoglobin (Hpt), an acute-phase protein
of inflammation, binds ApoE thus influencing stimulation of
cholesterol esterification by the enzyme lecithin: cholesterol acyl-
transferase and cholesterol uptake by hepatocytes (Cigliano et al.,
2009). Hpt is so far known for its role in Hemoglobin (Hb)
binding and transport to the liver (Quaye, 2008), and it was ini-
tially identified as a marker of blood-brain barrier dysfunction
(Chamoun et al., 2001). Further, some studies pointed out that
this protein may be produced in the brain in response to different
stress stimuli (Lee et al., 2002; Borsody et al., 2006; Zhao et al.,
2009), and increased level of Hpt was found in cerebrospinal flu-
ids (CSF) from patients with AD (Johnson et al., 1992), or other
neurodegenerative diseases such as Parkinson’ and Huntington’s
disease (Argüelles et al., 2010; Huang et al., 2011). Hpt colocal-
izes with amyloid plaques in AD (Powers et al., 1981), inhibits
amyloid beta (Aβ) fibril formation in vitro (Yerbury et al., 2009),
acting as extracellular chaperone, and was suggested as poten-
tial biomarker of AD (Thambisetty, 2010). We recently reported
that Hpt influences ApoE-dependent 24(S)-hydroxycholesterol
esterification (La Marca et al., 2014), a key step for cholesterol
removal from the brain. Although the role of Hpt in brain patho-
physiology has not been fully investigated to date, the ability of
Hpt to bind ApoE might disclose an intriguing scenario related
to the modulation of cholesterol metabolism in the brain. The
objective of this study was to evaluate whether Hpt influences
ApoE-dependent cholesterol efflux from astrocytes and choles-
terol incorporation in neurons. Moreover, as no data related to
modulation of Hpt expression in aging brain are available so far,
we studied the expression profiles of Hpt and ApoE in rat cerebral
cortex and hippocampus, regions involved in several cognitive
and motor functions, and very vulnerable to the aging process.
MATERIALS AND METHODS
MATERIALS
Bovine serum albumin fraction V (BSA), gelatin, lecithin, rab-
bit anti-human Hpt IgG, mouse anti-β actin IgG, goat anti-rabbit
Horseradish Peroxidase-conjugated IgG (GAR-HRP), goat anti-
mouse Horseradish Peroxidase-conjugated IgG (GAM-HRP),
and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide], were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Recombinant human ApoE2, ApoE3, and ApoE4 were
from PeproTech (London, UK). Goat anti-human ApoE IgG,
and rabbit anti-goat Horseradish Peroxidase-conjugated IgG
(RAG-HRP) were from Chemicon (Merk Chemicals Limited,
Nottingham, UK). Mouse anti-human ApoE IgG was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
The ApoE mimetic peptide 131EELRVRLASHLRKLRKLRLL150
was from INBIOS s.r.l. (Naples, Italy). Rabbit anti-rat Hpt
was from ICL Lab (distributed by Prodotti Gianni, Milano,
Italy). The dye reagent for protein titration, enhanced chemi-
luminescence (ECL) reagents, and the polyvinylidene difluoride
(PVDF) membrane were from Bio-Rad (Bio-Rad, Hercules, CA).
Polystyrene 96-wells ELISA MaxiSorp plates, with high affin-
ity to proteins with mixed hydrophilic/hydrophobic domains,
were purchased from Nunc (Roskilde, Denmark). Kodak Biomax
light film, Sephacryl S-200, CNBr-activated Sepharose 4 Fast
Flow and Blue Sepharose 6 Fast Flow resins were from GE-
Healthcare Life Sciences (Milano, Italy). DMEM and fetal bovine
serum (FBS) were from BioWhittaker (Verseviers, Belgium). L-
glutamine, Neuroblastoma growth supplement N2, penicillin
and streptomycin were from Gibco (Life Technologies Italy,
Monza, Italy). Cell culture flasks (25 cm2), 96-well cell culture
plates, and sterile pipettes of Beckton-Dickinson (Milan, Italy)
were used. [1α,2α-3H]-Cholesterol (52.5 Ci/mmol) and the liquid
scintillation counting cocktail Ultima Gold were obtained from
Perkin-Elmer (Boston, MA, USA).
PURIFICATION OF Hpt
Hpt was isolated from plasma of healthy subjects (phenotype 1-
1) by a multi-step purification procedure, based on a gel filtration
with a column of Sephacryl S-200, followed by an affinity chro-
matography with a column of Blue Sepharose 6 Fast Flow, and
finally by a further purification by affinity chromatography using
a Sepharose resin coupled to anti-Hpt IgG (Cigliano et al., 2009).
Hpt was over 98% pure, as assessed by SDS-PAGE and densit-
ometric analysis of Coomassie-stained bands. The molarity of
purified Hpt was determined by measuring the protein concen-
tration (Bradford, 1976) and calculating the molecular weight of
the monomer αβ as previously described (Cigliano et al., 2003).
CELL CULTURE
The human neuroblastoma cell line SH-SY5Y and the human
glioblastoma-astrocytoma cell line U-87 MG were kindly pro-
vided by the Institute of Genetics and Biophysics (CNR, Naples,
Italy). Cells (500,000) were seeded in 50ml tissue culture flasks
(25 cm2 surface), and grown in DMEM supplemented with 10%
FBS, 2mM L-glutamine, 100U/ml penicillin, and 100μg/ml
streptomycin (complete medium) at 37◦C and under humidified
atmosphere of 5% CO2 in air. The medium was changed twice a
week, and cells were sub-cultivated when confluent.
SH-SY5Y were differentiated to mature neuronal phenotype
by incubation in low-serum medium containing retinoic acid
(RA), essentially according to published procedures (Påhlman
et al., 1984; Nordin-Andersson et al., 2003). In detail, the com-
plete medium was changed to DMEM containing 0.5% FBS,
2mM L-glutamine, 100 IU/ml penicillin, 100μg/ml strepto-
mycin, 1% neuroblastoma growth supplement N2. Then, the cells
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were seeded into 96 well-plates (at 8000 cells/well density), and
allowed to attach for 4 h before adding RA (10μM final concen-
tration). After further 72 h of culture, the differentiated cells were
used for cell-based ELISA, and for cholesterol internalization or
toxicity assays.
U-87 MG were seeded into 96 well-plates (at 15,000 cells/well
density) in complete medium, and incubated (37◦C, 5%CO2) for
20 h. After removal of the medium, and washing with DMEM, the
cells were used for cell-based ELISA or for cholesterol efflux assays
as described below.
BINDING OF Hpt TO ApoE ISOFORMS
All experiments were carried out with liposome-embedded ApoE,
as this apolipoprotein, in brain, is mostly associated with HDL-
like particles (Vance and Hayashi, 2010). Liposomes containing
ApoE2, or ApoE3, or ApoE4 (ApoE: lecithin = 1:133 molar con-
tribution; namely LipoE2, LipoE3 or LipoE4) were prepared by
the cholate dialysis method (Chen and Albers, 1982; Salvatore
et al., 2009).
Hpt was diluted to a final concentration of 0.01mg/ml
(0.2μM) with coating buffer (7mM Na2CO3, 17mM NaHCO3,
1.5mM NaN3, pH 9.6). Aliquots (50μl) of Hpt were then incu-
bated overnight at 4◦C into the wells of a microtitre plate. After
four washes by T-TBS (130mM NaCl, 20mM Tris-HCl, 0.05%
Tween 20, pH 7.4) and four washes by high salt TBS (500mM
NaCl in 20mM Tris-HCl at pH 7.4), for removing the excess of
Hpt, the wells were blocked with PBS containing 1% BSA and 1%
gelatin (1 h, 37◦C). The wells were extensively washed, and then
incubated (2 h, 37◦C) with different amounts (0.005, 0.01, 0.025,
0.05, 0.1, 0.3, or 0.7μM in TBS) of each ApoE isoform (LipoE2,
LipoE3, or LipoE4). The amount of apolipoprotein bound to Hpt
was measured by incubating the wells with 60μl of goat anti-
ApoE IgG (1: 2500 dilution in T-TBS containing 0.25% BSA; 1 h,
37◦C), followed by 70μl of RAG-HRP IgG (1: 7000 dilution; 1 h,
37◦C). Color development was measured at 492 nm. Absorbance
values were converted to the percentage of the value obtained with
0.7μM Apolipoprotein (assumed as 100% of ApoE binding to
Hpt). Data were analyzed by a non-linear regression fit algorithm
by GraphPad Prism v 5.01, in order to obtain the dissociation
constant (Kd) of each ApoE isoform for Hpt.
ApoE BINDING TO SH-SY5Y AND U-87MG BY ELISA
The effect of Hpt addition on ApoE binding to cells was evalu-
ated on both differentiated SH-SY5Y and U-87 MG. As described
above, SH-SY and U-87MG were seeded into a 96-well plate
(8000 and 15,000 cells/well, respectively), and cultured for 72 h
in RA-supplemented medium or for 20 h in complete medium
respectively. After removal of the culture medium, the cells were
washed with DMEM, and then fixed by incubation (30min, 4◦C)
with 0.3% glutaraldheyde in PBS. After removing glutaraldheyde,
the wells were gentle washed with PBS, and finally blocked with
PBS containing 1% BSA and 1% gelatin (overnight, 4◦C). After
extensive washing, the wells were incubated (2 h, 37◦C) with
aliquots (55μl) from mixtures containing 0.4μM LipoE3 and
different concentrations of Hpt (0, 0.04, 0.1, 0.4, 1.6, 4, or 8μM).
The amount of LipoE bound to cells was measured by treatment
with mouse anti-ApoE IgG (1: 3000 dilution in PBS; 1 h, 37◦C),
followed by GAM-HRP IgG (1: 20000 dilution in PBS; 1 h, 37◦C),
and color development at 492 nm. Absorbance values were con-
verted to the percent of the value obtained in the absence of Hpt
(assumed as 100% of LipoE binding).
CHOLESTEROL EFFLUX ASSAY
Cellular cholesterol efflux from astrocytes was measured essen-
tially according to Kim et al. (2007). In detail, U-87 MG were cul-
tured (96 well-plates; 15,000 cells/well) in complete medium for
20 h. After medium removal, cells were rinsed with DMEM, and
labeled by incubation (20 h, 37◦C) with [1α,2α-3H]-Cholesterol
(52.5 Ci/mmol; 0.026μCi/well) in DMEM containing 0.5% FBS,
100 IU penicillin/ml, 100μg streptomycin/ml. The medium was
removed, cells were rinsed twice in DMEM and then incubated in
serum-free DMEM containing 0.2% BSA, 100 IU/ml penicillin,
100μg/ml streptomycin (BSA-supplemented DMEM), 0.15μM
LipoE (ApoE: lecithin = 1:133 molar contribution), as choles-
terol acceptor, and different amounts of Hpt (0, 0.5, 1.5, 3, or
5μM). Cells incubated in BSA-supplemented DMEM, or in BSA-
supplemented DMEM containing different Hpt concentrations
were used as controls. Media samples were collected after 5 h, and
cleared of any cellular debris by centrifugation at 400 g for 5min.
The cells were extensively washed with DMEM, lysed with 0.1M
NaOH, and finally centrifuged at 12000 g for 30min. Aliquots
(70μl) of supernatants and lysates were then analyzed by scin-
tillation counting, and cholesterol effluxed to the medium was
calculated as a percentage of total radioactivity in the cell lysates
and medium. Experiments were routinely performed in triplicate
and repeated three times.
CHOLESTEROL INCORPORATION ASSAY
The ApoE-dependent internalization of cholesterol into differen-
tiated SH-SY5Y was carried out essentially according to published
procedures (Garcia et al., 1996; Cigliano et al., 2009). In detail,
cells were seeded in low-serum medium (8000 cells per well)
into 96-well plate, as above described, and cultured for 72 h
in presence of RA. After medium removal, cells were rinsed
with DMEM, and incubated (3 h, 37◦C) in BSA-supplemented
DMEM containing labeled proteoliposome (ApoE final concen-
tration 10 nM; cholesterol final concentration 15 nM), unlabeled
liposome (cholesterol final concentration 80 nM) and different
amounts of Hpt (0, 0.25, 0.5, or 1.0μM). In control experiments,
Hb (2μM) or HSA (5μM) was added to the culture medium to
displace Hpt from proteoliposomes, or to verify the specificity of
Hpt effect, respectively.
The specific effect of Hpt interaction with ApoE was further
confirmed by incubating differentiated SH-SY5Y (3 h, 37◦C) in
BSA-supplemented DMEM containing labeled proteoliposome
(ApoE final concentration 10 nM; cholesterol final concentra-
tion 15 nM), unlabeled liposome (cholesterol final concentration
80 nM), different amounts of Hpt (0, 0.5, or 1.0μM), and differ-
ent amounts (0, 4, or 8μM) of a peptide mimicking the ApoE
sequence (131EELRVRLASHLRKLRKLRLL150; Salvatore et al.,
2009) involved in the binding with Hpt. A further control was car-
ried out by incubating cells in the presence of labeled proteolipo-
some, unlabeled liposome, 1.0μM Hpt and 7μg/ml monoclonal
anti-humanHpt IgG (Sigma-Aldrich, St. Louis, MO, USA). At the
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end of incubation, media samples were collected, and cleared of
any cellular debris by centrifugation at 400 g for 5min. The cells
were extensively washed with DMEM, lysed with 0.1M NaOH,
and finally centrifuged at 12,000 g for 30min. Aliquots (70μl)
of supernatants and lysates were then analyzed by scintillation
counting, and protein concentration in cell lysates was measured
by Bradford assay (Bradford, 1976). The amount of cholesterol
internalized was calculated as d.p.m in lysates permg cell protein.
Experiments were routinely performed in triplicate and repeated
three times.
Liposomes containing ApoE and lipids were prepared by the
cholate dialysis procedure (Chen and Albers, 1982), but with
an ApoE/lecithin/cholesterol molar ratio of 1: 100: 2 (Matz
and Jonas, 1982). [1α,2α-3H]-Cholesterol (specific activity 102.4
x106 dpm × nmol−1) in proteoliposome containing 10μMApoE
was used. Unlabeled liposome, prepared without apolipopro-
tein, was used to evaluate non-apolipoprotein-mediated uptake of
cholesterol. In detail, non-specific internalization was determined
in the presence of a 5-fold excess of the unlabeled cholesterol, and
represented about 50% of the total internalization.
ANALYSIS OF CHOLESTEROL EFFECT ON NEURONS VIABILITY
The effect of cholesterol on survival of differentiated SH-SY5Y
was evaluated using cholesterol embedded into liposome (choles-
terol/lecithin molar ratio 1/50) prepared by the cholate dialy-
sis method (Chen and Albers, 1982). Free ApoE was used for
promoting cholesterol incorporation.
SH-SY5Y were seeded in low-serum medium (8000 cells per
well) into 96-well plate, as above described, and cultured for 72 h
in presence of RA. After medium removal, cells were rinsed with
DMEM, and then incubated (20 h, 37◦C) in BSA-supplemented
DMEM containing free ApoE (final concentration 10 nM), and
different amounts of cholesterol (0, 1, 5, 15, or 30μM final
concentration). The medium was then removed and cell sur-
vival was evaluated by MTT assay. In detail, 100μl of MTT
(0.5mg/ml in DMEM without Phenol red) were added to each
well and the incubation was carried out for 3 h (37◦C). One
hundred micro liters of a solution containing 0.1M HCl in
isopropanol were then added to each well, and, after 30min,
the absorbance at 595 nm was measured with a Bio-Rad 3350
microplate reader. The data were expressed as viability per-
centage, assuming the absorbance value from cells cultured in
BSA-supplemented DMEM, containing 10 nM ApoE, as 100%.
The effect of Hpt on cholesterol-mediated cytotoxicity was
evaluated by incubating (20 h, 37◦C) differentiated SH-SY5Y
in BSA-supplemented DMEM containing free ApoE (final con-
centration 10 nM), cholesterol (15μM final concentration), and
different amounts of Hpt (0, 0.005, 0.01, or 0.05μM final con-
centration). Cell viability was then measured by MTT reduction
assay, as described above, and data were expressed as cell survival
percentage, assuming the absorbance value from cells cultured
without cholesterol as 100%.
ANIMAL AND EXPERIMENTAL DESIGN
Male Wistar rats (Charles River, Calco, Como, Italy) of 2 months
of age (adolescent), with the same starting body weight (160 ±
10 g), were individually caged in a temperature-controlled room
(23 ± 1◦C) with a 12-h light/12-h dark cycle. Animals were
housed in the Animal Care Facility at the Department of Biology,
with ad libitum access to water and to a standard diet (Mucedola
4RF21; Settimo Milanese, Milan, Italy) up to 5 (social maturity),
8 (adulthood), or 16 (middle-age) months. The animals of each
group (N = 8) were anesthetized by chloral hydrate (40mg/100 g
body wt) and killed by decapitation. The brains were quickly
removed and the cerebral cortex and hippocampus were dissected
on ice. Samples of each brain region were snap frozen in liquid
nitrogen immediately and stored at −80◦C for subsequent RNA
and protein isolation.
The protocols for animal care and use were approved by the
“Comitato etico-scientifico per la sperimentazione animale” of
the University “Federico II” of Naples. All experimental animal
procedures were carried out in compliance with national guide-
lines for the care and use of research animals (D.L.116/92, imple-
mentation of EEC directive 609/86). All efforts were made to
minimize animal suffering and to reduce the number of animals
used.
REAL-TIME PCR ANALYSIS
Total RNA was extracted according to the TRI-Reagent (Sigma
Aldrich) protocol. The concentration and purity of RNA sam-
ples were determined by UV absorbance spectrophotometry;
RNA integrity was checked on 1.2% agarose gel electrophore-
sis. First-strand cDNA was synthesized from each total RNA
(1μg) using the QuantiTect reverse transcription kit (Qiagen).
The Real Time PCR reactions were carried out in quadrupli-
cate in an Applied Biosystems 7500 Real Time System by using
the Power SYBR Green Master Mix PCR (Applied Biosystems).
Each SYBR Green reaction (20μl total volume) contained 2μl
of 1:1 diluted cDNA as template. For internal standard con-
trol, the expression of β-actin gene was quantified. Primer
sequences were designed using Primer Express software (Applied
Biosystems). ApoE primers were designed on the exon junc-
tion 82/83 (forward primer) on template NM138828.2 (for-
ward primer, 5′-GGTCCCATTGCTGACAGGATGCC-3′; reverse
primer, 5′-AGAAAGCGTCTGCACCCAGCG-3′); Hpt primers
were designed on the exon junction 278/279 (forward primer)
on template NM012582.2 (forward primer, 5′-TGAGGCAGTGT
GTGGGAAGCCC-3′; reverse primer, 5′-TGTGGCCCCAGTGGT
GAGTCC-3′); β-actin primers were designed on the exon
junction 75/76 (forward primer) on template NM031144.2
(forward primer, 5′-ACCCGCCACCAGTTCGCCAT-3′; reverse
primer, 5′-CGGCCCACGATGGAGGGGAA-3′). Amplicons were
128–136 bp long. The PCR was performed under the following
conditions: holding stage of 95◦C per 10′; cycling tage (45 cycles):
95◦C × 10 s–60◦C × 10 s–72◦C × 10 s; melting stage: 95◦C ×
5 s–65◦C × 1m–95◦C × 30 s–40◦C × 30 s.
PCR amplification efficiencies were determined for each gene
and  CT relative quantification was done using β-actin gene
expression as internal control to normalize the results.
ELECTROPHORESIS ANDWESTERN BLOTTING
Proteins were extracted from hippocampus and cortex by homog-
enizing frozen tissues (−80◦C) in 10 volumes (w/v) of cold
RIPA buffer (150mM NaCl, 50mM Tris-HCl, 1% NP-40, 0.5%
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sodium deoxycholate, pH 8) containing Tissue Protease Inhibitor
Cocktail (Sigma-Aldrich, 1:1000, v/v). Homogenates were then
centrifuged (14,000 g, 45min, 4◦C) and protein concentration of
supernatants was measured according to a published procedure
(Bradford, 1976).
Brain homogenates were fractionated by electrophoresis in
denaturing and reducing condition on 12.5% polyacrylamide gel,
as previously reported (Porta et al., 1999). In detail, samples
containing 35 or 50μg of proteins were analyzed for detect-
ing Hpt in cortex or hippocampus respectively, while samples
containing 60μg of proteins were analyzed for detecting ApoE.
After electrophoresis, proteins were transferred onto PVDFmem-
brane (1 h, under electric field), the membrane was rinsed in
T-TBS, and then blocked with T-TBS containing 5% non-fat milk
(overnight, 4◦C). The membrane was then incubated (1 h, 37◦C)
with rabbit anti-rat Hpt (1: 500 dilution in T-TBS containing
0.25% non-fat milk) followed by GAR-HRP IgG (1: 500 dilu-
tion; 1 h, 37◦C), or with goat anti-ApoE IgG (1: 1000 dilution
in T-TBS containing 0.25% non-fat milk; 1 h, 37◦C) followed
by RAG-HRP IgG (1: 3500 dilution;1 h, 37◦C). The immuno-
complexes were detected by the ECL detection system, using
luminol as substrate, according to the manufacturer protocol.
Quantitative densitometry of ApoE or Hpt was then carried
out by analyzing the digital images of membranes by the Gel-
Pro Analyzer software (Media Cybernetics, Silver Spring, MA).
Band intensities were calculated as Integrated Optical Density
(IOD).
After the first detection (Hpt or ApoE), the membrane was
extensively washed with T-TBS and then submerged in stripping
buffer (100mM β-mercaptoethanol, 2% SDS, 62.5mM Tris-HCl,
pH 6.7; 45min, 50◦C) for reprobing with anti-β-actin. After
washing with T-TBS, the membrane was incubated (1 h, 37◦C)
with mouse anti- β-actin IgG (1:2000 dilution), followed by
GAM-HRP IgG (1:10,000 dilution; 1 h, 37◦C). The immunocom-
plexes were detected by the ECL detection system, and densito-
metric analysis of the signal was carried out as above. Hpt and
ApoE concentrations, in hippocampus and cortex, were quanti-
fied after normalization with β-actin, and results were expressed
as arbitrary units.
ANALYSIS OF Hpt AND ApoE IN HUMAN CSF
CSF from younger healthy subjects (N = 13; 55–70 years) and
older healthy subjects (N = 12; 71–83 years), were provided by
P. Bongioanni (Pisa, Italy). The study conforms to The Code
of Ethics of the World Medical Association (Declaration of
Helsinki), and it was approved by the Ethics Committee of the
University of Naples Federico II.
ApoE and Hpt concentration in individual samples was mea-
sured by ELISA. Samples were diluted (1:100–1:800) with coating
buffer, and incubated in the wells of a microtitre plate (Immuno
MaxiSorp; overnight, 4◦C). After four washes by T-TBS and four
washes by high salt TBS, the wells were blocked with TBS contain-
ing 0.5% BSA (1 h, 37◦C). After washing, the wells were incubated
(1 h, 37◦C) with 60μl of goat anti-ApoE IgG (1: 3000 dilution
in T-TBS containing 0.25% BSA) followed by 60μl of RAG-
HRP IgG (1:14000 dilution) for immunodetection of ApoE, or
with 60μl of rabbit anti-Hpt IgG (1:1500 dilution) followed by
GAR-HRP IgG (1:8000 dilution) for Hpt detection. Peroxidase-
catalyzed color development from o-phenylenediamine was mea-
sured at 492 nm.
STATISTICAL ANALYSIS
In all experiments samples were processed in triplicate, and data
were expressed as mean value ± s.e.m. The program “GraphPad
Prism 5.01” (GraphPad Software, San Diego, CA) was used to
perform regression analysis, Student’s t-test, for comparing two
groups of data, and One-Way ANOVA, followed by Tukey’s test,
for multiple group comparisons. P < 0.05 was set as indicating
significance.
RESULTS
BINDING OF Hpt TO ApoE ISOFORMS
As functional differences among the three ApoE isoforms were
reported (Castellano et al., 2011; Hashimoto et al., 2012), we
firstly investigated whether the isoforms also differ for their ability
of binding Hpt. As shown in Figure 1, the amount of ApoE bound
to Hpt immobilized into the wells increased with the apolipopro-
tein concentration in the incubation medium. Kd of each LipoE
isoform was calculated as described inMaterial andMethods, and
we found that the three isoforms bind Hpt with similar affinity
(Kd LipoE2, 58.24 ± 11.78 nM; Kd LipoE3, 59.58 ± 11.71 nM;
Kd LipoE4, 54.88 ± 9.13 nM).
Hpt INFLUENCE ON ApoE BINDING TO CELLS
As cholesterol uptake by neurons and glial cells is mediated by the
binding of ApoE to specific cell surface receptors (Pfrieger and
FIGURE 1 | Binding of Hpt to ApoE isoforms. Aliquots of 0.2μM Hpt
were loaded into the wells of a microtitre plate, and then incubated with
different concentrations (0.005–0.7μM) of LipoE2 (open triangles), or
LipoE3 (open squares) or LipoE4 (solid squares). The amount of
apolipoprotein bound to Hpt was detected by goat anti-ApoE and RAG-HRP,
measured as absorbance at 492 nm, and reported as percentage of the
value obtained with 0.7μM protein (assumed as 100% of ApoE binding to
Hpt). Samples were processed in triplicate. Data were expressed as
mean ± s.e.m. vs.μmolar concentration.
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Ungerer, 2011), we investigated whether Hpt, due to its inter-
action with ApoE, displaces the apolipoprotein from binding
to neurons and astrocytes cell lines. Differentiated SH-SY5Y or
astrocytes were fixed into the wells of a 96-well plate, and then
incubated with mixtures containing 0.4μM LipoE3 and differ-
ent concentrations of Hpt 1-1 (0–8μM). As shown in Figure 2,
LipoE binding to cells decreased with the increasing of Hpt con-
centration in the incubation mixture. Indeed, Hpt significantly
reduced (p < 0.05) the binding of LipoE3 to both cell types, when
used at concentration higher than 0.04μM. In particular, LipoE
binding to SH-SY5Y and astrocytes was reduced of 20 and 15%
respectively (p < 0.03) by 0.1μM Hpt. Further, the binding to
neurons dropped down to 59 and 57% in presence of 0.4 and
1.6μM Hpt, respectively (p < 0.001), while the binding to astro-
cytes was reduced to 71 and 64% by the same Hpt concentrations
(p < 0.01). LipoE binding to SH-SY5Y was halved (p < 0.001) by
4 and 8μM Hpt (presumed 10 and 20-fold excess over ApoE in
themixture), while the binding to astrocytes was reduced to about
35% (p < 0.001) by the same concentrations. These results sug-
gest that Hpt interferes with ApoE binding to both neuron and
astrocyte cell lines, and this effect is more pronounced when the
Hpt/ApoE molar ratio increases.
Hpt EFFECT ON ApoE-DEPENDENT CHOLESTEROL EFFLUX FROM
ASTROCYTES
In order to evaluate Hpt effect on ApoE mediated cholesterol
efflux from astrocytes, cells were labeled with [3H]cholesterol
(0.52μCi/ml) for 20 h, and then incubated (5 h) in serum-free
DMEM containing 0.15μM LipoE and different amounts of
Hpt (0–5μM). We found that LipoE significantly stimulated
FIGURE 2 | Hpt influence on ApoE binding to cells. Differentiated
SH-SY5Y (8000 cells; full triangles) or U87-MG (15,000; open squares) were
fixed into the wells of a 96-well plate and then incubated with mixtures
containing 0.4μM LipoE3 and different concentrations of Hpt (0–8μM). The
amount of LipoE bound to cells was measured by incubation with mouse
anti-ApoE IgG, followed by GAM-HRP and color development at 492 nm.
Data are reported as percent of the value obtained by incubation in the
absence of Hpt (assumed as 100% of LipoE binding), and expressed as
mean ± s.e.m.
cholesterol efflux from astrocytes (p < 0.0001; Figure 3),
according with previous data (Kim et al., 2007), and this effect
was not impaired in the presence of Hpt, even at the highest
protein concentration used (presumed 33-fold excess over LipoE
in the mixture). These results suggest that Hpt binding to ApoE
does not interfere with cholesterol efflux from astrocytes, and that
ApoE retains the ability to stimulate this process also when the
Hpt/ApoE molar ratio increases. This might be due to differences
in the ApoE sequences involved in the interaction with Hpt and
with ABC transporter. Indeed we previously found that Hpt
engages the N-terminal region of the apolipoprotein (Salvatore
et al., 2009), while the binding of ApoE to the ABC transporters
is mediated by the C-terminal region (Vedhachalam et al., 2007).
Hpt EFFECT ON THE ApoE-MEDIATED CHOLESTEROL INCORPORATION
In order to investigate whether Hpt, interacting with ApoE,
affects cholesterol internalization by neurons, differentiated SH-
SY5Y were incubated (3 h, 37◦C) with labeled proteoliposome
(ApoE final concentration 10 nM; cholesterol final concentration
15 nM), and different amounts of Hpt (0–1μM).
[3H]-cholesterol was used as tracer. As shown in Figure 4A,
Hpt significantly inhibited the cholesterol uptake mediated by
ApoE at any assayed concentration (p < 0.005; Hpt/ApoE molar
ratios in the mixtures = 25:1, 50: 1, 100:1). In particular, 0.25μM
Hpt reduced cholesterol internalization of about 15% (p < 0.04),
FIGURE 3 | Hpt effect on ApoE-dependent cholesterol efflux. U87-MG
were seeded into 96-well plate (15,000 cells per well) and cultured in
complete medium for 20 h. After medium removal, cells were rinsed with
DMEM and labeled by incubation (20 h) with [3H]-Cholesterol (0.026
μCi/well) in DMEM containing 0.5% FBS. After medium removal, cells were
rinsed again, and incubated (5 h) in serum-free DMEM containing 0.2%
BSA in presence (open squares) or absence (full squares) of 0.15μM LipoE
and different amounts of Hpt (0–5μM). Aliquots (70μl) of supernatants and
lysates were then analyzed by scintillation counting, and cholesterol
effluxed to the medium was calculated as percentage of total radioactivity
in the cell lysates and medium. Data were expressed as mean ± s.e.m.
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FIGURE 4 | Hpt effect on ApoE-mediated cholesterol incorporation.
(A) Differentiated SHSY5Y were incubated into 96-well plate (3 h;
8 × 103 cells per well) with proteoliposome suspension containing
[3H]-cholesterol, phosphatidylcholine, and 10 nM ApoE. The assay was
performed in the absence (open bar, control) or presence of different
amounts of Hpt (0.25, 0.5 or 1μM; bars with vertical lines). Control
experiments were also carried out in presence of Hb (2μM; full bar)
or HSA (5μM, bar with horizontal lines). After incubation, the cells
were lysed for measurement of their radioactivity and protein
concentration. The amount of cholesterol internalized was measured
as dpm permg of cell protein. Significant differences from control are
indicated (∗p < 0.05; ∗∗p < 0.001). The samples were analyzed in
triplicate, and the data are expressed as means ± s.e.m. (B)
Differentiated SHSY5Y were incubated into 96-well plate (3 h; 8 × 103
cells per well) with proteoliposome suspension containing
[3H]-cholesterol, phosphatidylcholine, and 10 nM ApoE. The assay was
performed in the absence (open bar, control) or presence of different
amounts of Hpt (0.5 or 1μM; bars with vertical lines). Control
experiments were carried out in presence of 0.5μM Hpt and 4μM
ApoE mimetic peptide (131EELRVRLASHLRKLRKLRLL150; full bar), or in
presence of 1μM Hpt and different amounts of ApoE mimetic
peptide (4 or 8μM, full bars), or in presence of 1μM Hpt and
mouse anti-human Hpt IgG (7μg/ml, gray bar). After incubation, the
cells were lysed for measurement of their radioactivity and protein
concentration. The amount of cholesterol internalized was measured
as dpm permg of cell protein. Significant differences from control are
indicated (∗∗p < 0.001; ∗∗∗p < 0.0001). The samples were analyzed in
triplicate, and the data are expressed as means ± s.e.m.
while 0.5 and 1μM Hpt reduced the internalization of 45 and
50% (p < 0.002). These results indicate that Hpt, due to its
binding to ApoE, impaired the apolipoprotein in promoting
cholesterol uptake by neurons. The specificity of this effect was
confirmed by the finding that cholesterol internalization was fully
restored when internalization assays were performed in the pres-
ence of both Hb and Hpt (Hb/Hpt molar ratio = 2:1). Indeed
Hb is a high affinity ligand of Hpt (Bowman and Kurosky, 1982;
Polticelli et al., 2008), and displaces Hpt from ApoE (Cigliano
et al., 2009), which is therefore free to interact with cell recep-
tors. Incubation of proteoliposomes with Hb alone in the culture
medium did not affect cholesterol delivery to the cells. Uptake
inhibition was not observed when albumin, instead of Hpt, was
present in the culture medium.
Cholesterol internalization assays were also performed in the
presence of both Hpt and a synthetic peptide mimicking the
ApoE sequence involved in the binding to Hpt, in order to ver-
ify whether this peptide is able to rescue cholesterol uptake by
neurons. As shown in Figure 4B, cholesterol internalization was
reduced of 43% (p < 0.001) by 0.5μM Hpt, and it was fully
restored in the presence of 4μM peptide (peptide/Hpt molar
ratio 8:1). Further, cholesterol internalization was reduced of 54%
(p < 0.0001) by 1μMHpt, and it was restored to 78% of the con-
trol (p < 0.001) in the presence of 4μM peptide (peptide/Hpt
molar ratio 4:1), and to 97% of the control (p < 0.0001) in the
presence of 8μM peptide (peptide/Hpt molar ratio 8:1). These
results demonstrate that the ApoE mimetic peptide, as impair-
ing ApoE interaction with Hpt, works as Hpt antagonist, rescuing
the functional deficiency in cholesterol uptake, caused by Hpt.
In a further control, the internalization assay was carried out in
the presence of both Hpt (1μM) and a monoclonal anti-human
Hpt antibody (7μg/ml). In these conditions cholesterol uptake
was restored to 90% of the control (Figure 4B; p < 0.0001).
These results confirm that the impairment of cholesterol uptake
specifically depends on the Hpt binding to ApoE.
Hpt INFLUENCE ON CHOLESTEROL-MEDIATED TOXICITY
It is well known that cholesterol may be toxic to its host cell, and
when accumulated, it causes cell death (Liu et al., 2010). Since
ApoE mediates cholesterol internalization by neurons, we then
investigated whether Hpt, by binding ApoE, was able to modulate
cholesterol neurotoxicity.
Toxic cholesterol concentrations for differentiated SH-SY5Y
were determined in a preliminary experiment, by incubating cells
with different amounts of cholesterol (0–30μM) in the presence
of ApoE (10 nM final concentration). As shown in Figure 5A,
cholesterol treatment decreased the cell viability of differentiated
SH-SY5Y in a dose-dependent manner. In particular, the treat-
ment with 15 or 30μM cholesterol reduced cell viability to 43.6%
(p = 0.004) or 19.8% (p = 0.0001) respectively. Data were ana-
lyzed by non-linear regression and the EC50 value was 26.7μM.
The cholesterol concentration 15μM was therefore chosen for
further experiments, carried out in the presence of Hpt.
Differentiated SH-SY5Y were incubated with 15μM choles-
terol and different amounts of Hpt (0–0.05μM), in the presence
of 10 nM ApoE. As shown in Figure 5B, only 44% of cells sur-
vived after treatment with 15μM cholesterol, and cell viability
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FIGURE 5 | Effect of Hpt on cholesterol-mediated neurotoxicity. (A)
Differentiated SHSY5Y were incubated into 96-well plate (20 h; 8 × 103 cells
per well) in DMEM containing 0.2% BSA, 10 nM ApoE, and different
amounts of liposome-embedded cholesterol (0–30μM). Cell survival was
evaluated by MTT assay, and it was expressed as percentage of viability of
the control (cells cultured without cholesterol addition; open square).
Significant differences from control are indicated (∗∗p < 0.005;
∗∗∗p < 0.001). Data are reported as mean ± s.e.m. (B) Differentiated
SH-SY5Y were incubated into 96-well plate (20 h; 8 × 103 cells per well) in
DMEM containing 0.2% BSA, 10 nM ApoE, 15μM liposome-embedded
cholesterol, and different amounts of Hpt (0.005, 0.01, or 0.05μM; bars with
vertical line). Cell survival was evaluated by MTT assay, and it was expressed
as percentage of viability of the control (cells cultured without cholesterol
and Hpt; open bar). Significant differences from cells treated by cholesterol
(full bar) are indicated (∗∗∗p < 0.001). Data are reported as mean ± s.e.m.
was found significantly higher (p < 0.001) when incubation with
cholesterol was performed in presence of Hpt. In particular,
cell survival was restored to 75% of the control (p < 0.001) by
0.01μM Hpt, and to 90% of the control (p < 0.001) when treat-
ment was carried out in the presence of 0.05μM Hpt. These
data confirm that Hpt, by binding ApoE, influences the ApoE-
mediated cholesterol internalization into neuron cell lines, and
suggest that Hpt might play a neuroprotective effect when cells
are exposed to toxic amounts of cholesterol.
ANALYSIS OF Hpt AND ApoE IN HIPPOCAMPUS AND CEREBRAL
CORTEX OF RATS
As no previous data are available on the effect of aging on
brain expression of Hpt, we evaluated Hpt and ApoE (mRNA
and protein levels) in hippocampus and in cortex of adolescent
(2 month-old), adult (5 and 8 months-old), and middle-aged
(16 month-old) rats. Real Time-PCR revealed a significant age-
related increase of ApoE expression, which was different between
the two brain regions (Figures 6, 7). In particular, the level
of ApoE mRNA linearly increased with the age from 2 to 8
months in the hippocampus (Figure 6, p = 0.03, r = 0.99), while
it remained unchanged in the cortex (Figure 7) until 8 months,
with a significant increase in the cortex of rats of 16 months
compared to the rats of 2 months (p < 0.05). Western blotting
analysis revealed that ApoE level in the hippocampus, increased
(about 2.9 fold; p < 0.001) in 5 month-old rats compared to 2
months, but did not further change with aging (Figure 6). In
the cortex, ApoE concentration increased in 5 and 8 month-old
rats compared to 2 month-old rats (1.6 and 1.8 fold respectively,
p < 0.001), while a mild reduction was detected in 16-month-old
rats when compared to 5 month-old (about 1.2 fold, p < 0.05)
and 8 month-old (about 1.4 fold, p < 0.01; Figure 7). The appar-
ent discrepancy between mRNA and protein level was observed
for many proteins in mammalian cells and could be due, at least
in part, to the age-related modifications in translation and/or
post translation processes (Nelson and Keller, 2007). Differences
in the age-dependent changes of ApoE, between hippocampus
and cortex, might be due to differences in cellular composi-
tion of the two cerebral compartments. The analysis of Hpt
expression in hippocampus revealed that mRNA level was sig-
nificantly lower in 2 month- than in 8 and 16 month-old rats
(p < 0.05), while no differences were found among the other
groups (Figure 6). Interestingly, Hpt concentration, as detected
by Western blotting, significantly increased with the age till 8
months. As matter of fact, Hpt level in hippocampus of 2 month-
old rats did not differ from that of 5 months, but was 2.8 fold
lower than that of 8 month-old (p < 0.001, Figure 6) and 3.3
fold lower than that of 16 month-old rats (p < 0.001; Figure 6).
Further, Hpt concentration was about 2-fold higher in hippocam-
pus of 8 month-old rats compared to 5 month-old (p < 0.05).
Conversely, no age related changes of Hpt levels and mRNA were
found in the cortex (Figure 7). The finding of Hpt mRNA in hip-
pocampus and cerebral cortex confirms a local synthesis of Hpt
in brain, which is independent from the level of the protein in
plasma. Altogether these results suggest that aging is associated
with changes, particularly in the hippocampus, in the Hpt/ApoE
ratio.
ANALYSIS OF Hpt AND ApoE IN HUMAN CSF
Hpt and ApoE concentrations were measured by ELISA in CSF
samples collected from healthy subjects with age between 55 and
83 years. In detail, the samples were divided into two different
groups including younger subjects (55–70 years) and older sub-
jects (71–83 years). We found that Hpt concentration was signifi-
cantly lower (p = 0.02) in CSF from younger donors than in CSF
from older donors (1.067 ± 0.170μg/ml vs. 2.080 ± 0.405μg/ml;
Figure 8), while ApoE level did not differ between the two
age groups (2.148 ± 0.307μg/ml vs. 2.490 ± 0.299μg/ml).
Hpt/ApoE molar ratio was lower in CSF from younger than
older subjects (0.327 ± 0.060 vs. 0.656 ± 0.110μg/ml; p = 0.01;
Figure 8). As CSF is the biological fluid representative of the brain
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FIGURE 6 | Hpt and ApoE expression in rat hippocampus. Hpt (left side)
and ApoE (right side) protein and mRNA levels in hippocampus of 2, 5, 8, and
16 month-old rats are shown. Representative Western blots stained with
anti-Hpt (left) or anti-ApoE (right) IgG, and anti-actin IgG are shown. Samples
were analyzed by 12.5% SDS-PAGE and western blotting. Immunocomplexes
were detected by rabbit anti-Hpt and GAR-HRP IgGs (on the left) or by goat
anti-ApoE and RAG-HRP IgGs (on the right). After Hpt or ApoE detection, the
membrane was stripped for reprobing with anti-β-actin. Quantitative
densitometry of ApoE, Hpt, and β-actin was carried out and band intensities
were calculated. Hpt and ApoE concentrations are shown relative to β-actin
level. mRNA level of Hpt and ApoE are shown relative to the β-actin mRNA.
The data represent the mean ± s.e.m. (eight rats per group). Significance of
differences is shown. ∗p < 0.05 vs. 2 months; ∗∗p < 0.001 vs. 2 months.
ap < 0.05 vs. 5 months; aap < 0.001 vs. 5 months.
microenvironment, these results suggest that age-related changes
of Hpt concentration occur in human central nervous system.
DISCUSSION
Aging is the dominant non-genetic risk factor for AD (Cummings
and Cole, 2002), as it contributes to the physiological decline,
and is associated, in the brain, with increased oxidative damage,
inflammation, protein aggregate accumulation, demyelination,
and very selective and modest neuron and synapse loss (Lee
et al., 2000; Bartzokis et al., 2007). However, AD development
also depends on multiple genetic and environmental risk factors.
The E4 allele of ApoE represents by far the strongest and best
established genetic risk factors for AD (Liu et al., 2013). ApoE4
isoform was reported to contribute to AD pathogenesis through
both Aβ-dependent and Aβ-independent pathways (Liu et al.,
2013). As ApoE plays a key role in modulating brain cholesterol
trafficking, and dysregulation of cholesterol balance in brain is
increasingly being correlated to AD (Vance, 2012), the evaluation
of inflammatory- and non-inflammatory players, able to influ-
ence ApoE key activity in cholesterol or Aβ metabolism might
represent an alternative approach to elucidate the link among
AD pathogenesis, ApoE, and cholesterol metabolism. We pre-
viously reported that Hpt binds ApoE and affects both ApoE
stimulation of lecithin:cholesterol acyltransferase and cholesterol
delivery to hepatocytes (Cigliano et al., 2009). Here we report
that the binding between Hpt and ApoE does not influence
ApoE-dependent cholesterol efflux from astrocytes, which occurs
through ABC transporters, but impairs the cholesterol delivery,
mediated by ApoE, from reconstituted lipoproteins to neuron
cell lines. These results suggest that Hpt binding to ApoE does
not interfere with ApoE binding to ABC transporters, but might
limit ApoE interaction with cell receptors. This is in agreement
with our previous finding that Hpt binds the ApoE sequence
131EELRVRLASHLRKLRKLRLL150 localized in the helix 4 of
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FIGURE 7 | Hpt and ApoE expression in rat cerebral cortex. Hpt (left side)
and ApoE (right side) protein and mRNA levels in cortex of 2, 5, 8, and 16
month-old rats are shown. Representative Western blots stained with
anti-Hpt (left) or anti-ApoE (right) IgG, and anti-actin IgG are shown. Samples
were analyzed by 12.5% SDS-PAGE and western blotting. Immunocomplexes
were detected by rabbit anti-Hpt and GAR-HRP IgGs (on the left) or by goat
anti-ApoE and RAG-HRP IgGs (on the right). After Hpt or ApoE detection, the
membrane was stripped for reprobing with anti-β-actin. Quantitative
densitometry of ApoE, Hpt, and β-actin was carried out and band intensities
were calculated. Hpt and ApoE concentrations are shown relative to β-actin
level. mRNA level of Hpt and ApoE are shown relative to the β-actin mRNA.
The data represent the mean ± s.e.m. (eight rats per group). Significance of
differences is shown. ∗p < 0.05 vs. 2 months; ∗∗p < 0.001 vs. 2 months.
bp < 0.05 vs. 16 months; bbp < 0.001 vs. 16 months.
the N-terminal region of the apolipoprotein (Salvatore et al.,
2009). As this sequence also contains the receptor-binding region
(residues 136–150) (Guttman et al., 2010; Liu et al., 2013), it
is conceivable that Hpt masks by steric hindrance the ApoE
domain involved in the interaction with the receptors, thus reduc-
ing cholesterol internalization by neurons. Accordingly, we found
that the inhibitory effect of Hpt was reduced or abolished in the
presence of a synthetic peptide that mimics the ApoE sequence
involved in the binding to Hpt, as well as in the presence of the
higher affinity ligand of Hpt, that is Hb (Bowman and Kurosky,
1982; Polticelli et al., 2008). In this frame, it is worth mention-
ing that cholesterol, even though modulating cellular metabolism
can be also toxic to its host cell, and when accumulated, it
causes cell death (Liu et al., 2010). Our results from in vitro
investigations demonstrate that Hpt, at concentration similar to
those measured in human CSF, plays a neuroprotective effect,
reducing the toxic effect on neurons of increasing concentrations
of cholesterol. Beneficial effects of Hpt were already reported,
since we previously demonstrated that it protects ApoE from
oxidative damage (Salvatore et al., 2009). In addition, this gly-
coprotein was shown to protect neuroblastoma cells from Aβ
toxicity and promote the peptide uptake in macrophage-like cells
(Yerbury and Wilson, 2010). Also, it plays an important role in
defending neurons from damage, by neutralizing iron-rich Hb
released into the brain parenchyma, after intracerebral hemor-
rhage (Zhao et al., 2009). Our results suggest a potential role
of Hpt in modulation of brain cholesterol in addition to that
played in circulation. In fact, we previously reported that Hpt
influences the reverse cholesterol transport in blood, in both
healthy subjects and rheumatoid arthritis patients (Cigliano et al.,
2005), as well as in a mouse model of inflammation (Bucci et al.,
2012).
Age-related variations of Hpt and ApoE might affect choles-
terol metabolism and cell survival in brain.
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FIGURE 8 | Hpt concentration and Hpt/ApoE molar ratio in human CSF.
Hpt and ApoE concentrations were measured, by ELISA, in human CSF
samples obtained from younger subjects (N = 13; aged 55–70 years) and
older subjects (N = 12, aged 71–83 years). Each sample was analyzed in
triplicate. Data are reported as mean ± s.e.m. Significant differences
between groups are indicated (∗p = 0.02; ∗∗p = 0.01).
Therefore we investigated whether changes of both proteins
occur with aging in rats’ hippocampus and cerebral cortex. ApoE
concentration, in brain, was previously reported to be affected
by age (Perovic et al., 2009), and our data are consistent with
these results. A recent microarray analysis on hippocampal tissue
showed that Hpt was between the selective transcripts induced by
injections into mice hippocampus of a cocktail of tumor necrosis
factor TNF-α, interleukin (IL)-12, and IL-1b (Lee et al., 2013).
Interestingly, we here show, for the first time, that Hpt pro-
tein and mRNA level significantly change during aging in rat
hippocampus. In particular, Hpt concentration in hippocam-
pus significantly increases from adolescence to middle-age, while
ApoE level was lower in adolescent rats than in all other groups,
but did not change from adulthood tomiddle-age. The increase of
Hpt/ApoE ratio during aging, in this brain compartment, might
affect the neurons ability to recognize ApoE-containing lipopro-
teins, thus influencing the concentration of brain circulating
lipids and modulating neurons uptake of cholesterol. Age-related
changes of Hpt concentration were also found in human CSF
obtained from subjects of different ages. Indeed, Hpt level was
raised 2-fold in subjects aged 71-83 years with respect to sub-
jects aged 55–70 years thus suggesting that aging is associated
with changes of this protein also in human brain. Since choles-
terol metabolism in the different brain regions is not uniform
and, during normal aging, brain levels of this lipid differen-
tially change depending on the region considered and cell-type
studied (Martin et al., 2010), any age-related change in brain
Hpt expression could have important implications. The increase
of Hpt level might have deep impact in brain pathophysiol-
ogy, modulating cholesterol internalization and protecting cells
from cholesterol toxicity or oxidative stress, by ApoE-dependent
and/or ApoE-independent mechanisms. Hpt might thus be a pro-
tective factor for ApoE function or a proinflammatory culprit
during neuroinflammation. In fact, it cannot be excluded that
enhanced Hpt levels, by limiting cholesterol uptake by neurons,
might represent a further way by which inflammation worsens
the onset and the rate of progression of neurodegeneration. We
cannot assess, to date, whether the positive effects of Hpt in brain
outweigh the negative effects, or vice versa. How exactly Hpt
and ApoE conspire to influence neuronal functions and survival
remains to be determined. However, our findings provide, for the
first time, insight into the modulation of Hpt expression in aging
brain, and lay the groundwork for future studies on Hpt role in
brain.
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